Litigation for RIVAROXABAN

US Court Litigation for RIVAROXABAN

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
10,828,310	Bayer Pharma AG v. Accord Healthcare Inc.	1:21-cv-00566|D. Del.	2021-04-22	2021-07-29	35:271 Patent Infringement	District Court, D. Delaware	None
10,828,310		1:22-cv-00165|D. Del.	2022-02-04	2022-07-12	35:271 Patent Infringement	District Court, D. Delaware	None
10,828,310		1:22-cv-01596|D. Del.	2022-12-14		35:271 Patent Infringement	District Court, D. Delaware	None
10,828,310	Bayer Intellectual Property GmbH v. Biocon Pharma Limited	1:23-cv-00334|D. Del.	2023-03-24	2023-08-07	35:271 Patent Infringement	District Court, D. Delaware	None
10,828,310	Bayer Pharma AG v. Dr. Reddy's Laboratories, Ltd.	1:23-cv-00410|D. Del.	2023-04-13		35:271 Patent Infringement	District Court, D. Delaware	None
10,828,310	Bayer Pharma AG v. Teva Pharmaceuticals USA, Inc.	1:23-cv-00551|D. Del.	2023-05-19		35:271 Patent Infringement	District Court, D. Delaware	None
10,828,310		1:23-cv-00556|D. Del.	2023-05-19	2024-03-14	35:1 Patent Infringement	District Court, D. Delaware	None

Patent Trial and Appeal Board Cases for RIVAROXABAN

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
10,828,310	Mylan Pharmaceuticals Inc. et al.		2022-02-02	02-02-2022		Inter partes review		08-09-2022
10,828,310	Teva Pharmaceuticals USA, Inc		2022-09-09	09-09-2022		Inter partes review		10-19-2022
10,828,310	InvaGen Pharmaceuticals, Inc. et al.		2022-09-08	09-08-2022		Inter partes review		10-19-2022
7,157,456	Mylan Pharmaceuticals Inc et al.		2016-10-07	10-07-2016	Straub et al	Inter partes review
7,585,860	Mylan Pharmaceuticals Inc. et al.		2016-10-07	10-07-2016	Straub et al	Inter partes review
7,592,339	Mylan Pharmaceuticals Inc. et al.		2016-10-07	10-07-2016	Straub et al	Inter partes review
9,539,218			2014-01-30			201